Additional European Equity News
AstraZeneca (AZN LN) - Tagrisso with the addition of chemotherapy approved in the EU as new 1st-line treatment for patients with EGFR-mutated advanced lung cancer. (AstraZeneca)
Atos (ATO FP) - Secured short-term funding via a syndication agreement, under the EUR 1.5bln term loan of the Co.. Restructuring operations to be implemented in H2. (Newswires)
Saab (SAAB SS) - Co's new navigation system has been approved for use within the Panama Canal. (Newswires)
Shell (SHEL LN) - Co. expects a non-cash post tax impairment of USD 1.5-2.0bln in Q2. Q2: Upstream production seen at 1720-1820k/BOEPD; Integrated gas production 940-980k/BOEPD. (Shell)
05 Jul 2024 - 07:10- EquitiesEU Research- Source: Newsquawk
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts